According to the official report, the health services have so far applied 57.8 million injections, including 36.9 million injections for the first dose of treatment, and 20.8 million for the second and final dose.
The government’s plan, which this week called on those over the age of 36 to go to vaccination centers, is that by the end of July, all adults in the UK, estimated at 53 million people, will have the opportunity to be immunized against COVID-19. -19.
However, there are concerns that the spread of one of the types of SARS-CoV-2 that was initially identified in India in the British territories could nullify the effectiveness of vaccines, and this is the reason for conducting a clinical trial with a third dose of reactivation.
In a televised press conference, Health Secretary Matt Hancock explained that in the study that the University of Southampton Hospital will conduct with 2,886 volunteers, seven vaccines will be tested.
The official said I have been urging everyone who already has doses and is eligible to join the trial and help protect the most vulnerable people in this country and in the world for months and years.
However, Hancock stressed that so far there is no indication that the virus is a strain from India that, despite being more contagious than others prevalent in the United Kingdom, is resistant to Covid-19 vaccines.
On Wednesday, the health authorities reported 2,696 cases of the SARS-Covid-2 virus that causes Covid-19 disease, and three other deaths, with a total of more than four million, 452 cases and 127 thousand 694 deaths since the beginning of the epidemic. .
Ok / nm